51 – 60 of 79
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Exploring the link between MORF4L1 and risk of breast cancer
(
- Contribution to journal › Article
-
Mark
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
(
- Contribution to journal › Article
-
Mark
Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
(
- Contribution to journal › Article
-
Mark
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
(
- Contribution to journal › Article
-
Mark
Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen.
(
- Contribution to journal › Article
- 2010
-
Mark
Homeobox transcription factor muscle segment homeobox 2 (Msx2) correlates with good prognosis in breast cancer patients and induces apoptosis in vitro
(
- Contribution to journal › Article
-
Mark
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
(
- Contribution to journal › Article
-
Mark
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
(
- Contribution to journal › Article
-
Mark
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women
(
- Contribution to journal › Article